BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Qin TJ, An GL, Zhao XH, Tian F, Li XH, Lian JW, Pan BR, Gu SZ. Combined treatment of oxaliplatin and capecitabine in patients with metastatic esophageal squamous cell cancer. World J Gastroenterol 2009; 15(7): 871-876 [PMID: 19230050 DOI: 10.3748/wjg.15.871]
URL: https://www.wjgnet.com/1007-9327/full/v15/i7/871.htm
Number Citing Articles
1
D-W Zhang, H-L Li, Q Yao, W-L Yang, H-L Wang, D-X Zhai, Z-H Zhou. The Synergistic Effect of Recombinant Human Endostatin (YH-16) Combined with Oxaliplatin on Human Colorectal CarcinomaJournal of International Medical Research 2010; 38(1): 111 doi: 10.1177/147323001003800113
2
Ken Kato. Esophageal Squamous Cell Carcinoma2020; : 253 doi: 10.1007/978-981-15-4190-2_15
3
Tak Yun, Ji-Youn Han, Jin Soo Lee, Hyun Lee Choi, Hyae Young Kim, Byung-Ho Nam, Heung Tae Kim. Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinomaBMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-385
4
Femke M. de Man, Ruben A.G. van Eerden, Esther Oomen-de Hoop, Joris N. Veraart, Nadia van Doorn, Leni van Doorn, Ate van der Gaast, Ron H.J. Mathijssen. Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer PatientsCancers 2019; 11(6): 826 doi: 10.3390/cancers11060826
5
Ruyue Yang, Wenhui Yue, Dong Hu, Guidan Wang, Longfei Mao, Jiahe Huang, Huili Wang, Gaofeng Liang. Synthesis of compounds based on the active domain of cabotegravir and their application in inhibiting tumor cells activityChemistryOpen 2024; 13(7) doi: 10.1002/open.202300284
6
Kenneth K. Wang. Principles of Deglutition2013; : 579 doi: 10.1007/978-1-4614-3794-9_41
7
Ka On Lam, Wendy W. L. Chan, Tsz Him So, Dora L. W. Kwong. Esophageal Squamous Cell CarcinomaMethods in Molecular Biology 2020; 2129: 321 doi: 10.1007/978-1-0716-0377-2_24
8
Zhihao Lu, Yanqiao Zhang, Qingxia Fan, Yueyin Pan, Da Jiang, Ping Lu, Jingdong Zhang, Xianglin Yuan, Jifeng Feng, Shujun Yang, Wenbin Yue, Lin Zhao, Yunhua Xu, Jinhua Luo, Lin Shen. Paclitaxel and cisplatin with or without cetuximab in metastatic esophageal squamous cell carcinoma: a randomized, multicenter phase II trialThe Innovation 2022; 3(3): 100239 doi: 10.1016/j.xinn.2022.100239
9
Iago Dillion Lima Cavalcanti. Chemotherapy Protocols and Infusion Sequence2022; : 125 doi: 10.1007/978-3-031-10839-6_5
10
Setsuo Utsunomiya, Keisuke Uehara, Takuya Kurimoto, Ken Hirose, Masahide Fukaya, Yu Takahashi, Yoshiro Taguchi, Keita Itatsu, Masato Nagino. Synchronous rectal and esophageal cancer treated with chemotherapy followed by two-stage resectionWorld Journal of Clinical Cases 2013; 1(2): 87-91 doi: 10.12998/wjcc.v1.i2.87
11
Jianmin Tian, Kenneth K. Wang. Handbook of Gastrointestinal Cancer2012; : 1 doi: 10.1002/9781118423318.ch1
12
Usha Malhotra, Sarbajit Mukherjee, Christos Fountzilas, Patrick Boland, Austin Miller, Santosh Patnaik, Kristopher Attwood, Sai Yendamuri, Araba Adjei, Eric Kannisto, Mateusz Opyrchal, Peter Bushunow, Peter Loud, Renuka Iyer, Nikhil Khushalani. Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular CorrelatesMolecular Cancer Therapeutics 2020; 19(1): 304 doi: 10.1158/1535-7163.MCT-19-0240
13
Su Jin Lee, Sungmin Kim, Moonjin Kim, Jeeyun Lee, Yeon Hee Park, Young-Hyuck Im, Se Hoon Park. Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II studyBMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1716-9
14
Rachel L. Blom, Sjoerd M. Lagarde, Kim van Oudenaarde, Jean H. G. Klinkenbijl, Maarten C. Hulshof, Hanneke W. van Laarhoven, Jacques J. Bergman, Olivier R. Busch, Mark I. van Berge Henegouwen. Survival After Recurrent Esophageal Carcinoma Has Not Improved Over the Past 18 YearsAnnals of Surgical Oncology 2013; 20(8): 2693 doi: 10.1245/s10434-013-2936-3
15
Ken Kato. Esophageal Squamous Cell Carcinoma2015; : 197 doi: 10.1007/978-4-431-54977-2_12
16
Jialei Wang, Jianhua Chang, Hui Yu, Xianghua Wu, Huijie Wang, Wenhua Li, Dongmei Ji, Wei Peng. A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagusCancer Chemotherapy and Pharmacology 2013; 71(4): 905 doi: 10.1007/s00280-013-2081-5
17
Wanghua Chen, Wenling Wang, Yuxin Li, Hongmin Dong, Gang Wang, Xiaokai Li. Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancerCancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0608-x